County Bank

Home | Facebook | Twitter
GwdToday | Greenwood, SC
• Greenwood
• Lakelands & beyond
• School & College
• Sports
• Lake Greenwood
• Church News
• Events
• Closings & Delays
• Occasions
• Notices
2018 Holiday Season
• Recipes & more
• Giving Thanks
• Holiday Events
• Promotions
• Classifieds
• Employment
• Yard Sales
• Add Product/Service
• Add Classifieds

Kirks Pool
• Restaurant Specials
• Special Events
• Promotions
Crime Network
• Arrest Reports
• SC Sex Offenders
• Obituaries

Compton Law Firm
Cambridge Academy

home : news : greenwood November 18, 2018

Pediatric Dentistry Top HP

Climate Control HP

10/30/2018 9:13:00 AM
GGC's New Director of Research, Richard Steet, PhD, Receives $1.2 Million NIH Grant Renewal

The Greenwood Genetic Center’s (GGC’s) new Director of Research, Richard Steet, PhD, is bringing big changes to the Center. Steet, who joined GGC in August from the University of Georgia, and his longtime collaborator, Heather Flanagan-Steet, PhD, have developed an aquaculture facility at the Center for the study of zebrafish, a model organism for human genetic disorders.

And now Steet has successfully renewed a National Institutes of Health R01 grant from the National Institute of General Medical Sciences which will bring $1.2 million dollars to the Center’s Division of Research over the next four years.

The grant titled “Pathogenic Mechanisms of Lysosomal Disease” allows Steet and colleagues to continue their prolific work in using zebrafish models of a rare lysosomal storage disorder known as mucolipidosis II (MLII). Patients with MLII have coarse facial features, significant skeletal and joint abnormalities, intellectual disability, and a significantly shortened life span.

Steets’ previous work on MLII has identified that enzymes called cathepsins are key to the abnormal cartilage development associated with MLII. This discovery has led to a possible new treatment strategy for patients with MLII that will target the excessive activity of these enzymes outside the cell. Earlier studies in zebrafish have shown that this strategy can rescue many of the features of MLII.

This new round of funding will focus on the role of sugar polymers called GAGs in the disease process. Studies will assess how these polymers regulate the activation and activity of the cathepsins.

“This project highlights the value of using the zebrafish system to study genetic disorders,” said Steet, “Using zebrafish allows us to not only better understand the disease process, but also allows us to identify treatment targets and test those treatments. We look forward to expanding this work at GGC in the coming years.”

Article Comment Submission Form
Please feel free to submit your comments.

Article comments are not posted immediately to the Web site. Each submission must be approved by the Web site editor, who may edit content for appropriateness. There may be a delay of 24-48 hours for any submission while the web site editor reviews and approves it.

Note: All information on this form is required. Your telephone number is for our use only, and will not be attached to your comment.
Submit an Article Comment
First Name:
Last Name:
Anti-SPAM Passcode Click here to see a new mix of characters.
This is an anti-SPAM device. It is not case sensitive.

Advanced Search

Home | Facebook | Twitter • 720 Montague Ave Suite 314 • Greenwood • SC • 29649 •
Software © 1998-2018 1up! Software, All Rights Reserved